• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Pharmacovigilance Analytics

Your best resource for PV analytics news, content and innovation!

  • Home
  • Pharmacovigilance Analytics
    • Sources of data
    • Methods and tools
  • Signal Detection and Management in Pharmacovigilance
  • News
  • Opinion
  • About
  • Glossary

Glossary

AJAX progress indicator
Search: (clear)
  • a

  • Absolute Risk
  • Acceptable Risk
  • Active Surveillance
  • Adverse Drug Reaction (ADR)
  • Adverse Event (AE)
  • Adverse Event of Special Interest
  • Analysis of Covariance (ANCOVA)
  • b

  • Bayesian
  • Bayesian Confidence Propagation Neural Network (BCPNN)
  • Benefit-Risk Assessment
  • Bias
  • Big Data
  • Biomarker
  • Boxed Warning
  • c

  • Case Report Form (CRF)
  • Causality Assessment
  • Claims Data
  • Clinical Endpoint
  • Clinical Review
  • Clinical Trial
  • Cohort Event Monitoring
  • Cohort Study
  • Company Core Safety Information (CCSI)
  • Compliance Monitoring
  • Contingency Table
  • Covariance
  • Covariate
  • Cox model
  • d

  • Data Mining
  • Designated Medical Event (DME)
  • Development International Birth Date (DIBD)
  • Dosage Strength
  • Drug Master File - DMF
  • Drug Safety
  • Drug Substance (DS)
  • e

  • E-Value
  • Efficacy Evaluation
  • Electronic Data Capture (EDC)
  • Emerging Safety Issue
  • Excipient
  • g

  • Geographic Information Systems (GIS)
  • Good Pharmacovigilance Practice (GPvP)
  • i

  • Individual Case Safety Report (ICSR)
  • International Council for Harmonisation (ICH)
  • k

  • Key Performance Indicators (KPI)
  • Knowledge Graph
  • l

  • Literature Based Discovery [LBD]
  • m

  • Medical Dictionary for Regulatory Activities (MedDRA)
  • n

  • Non-Interventional Post-Authorization Safety Studies (NI-PASS)
  • o

  • OHDSI
  • OMOP
  • Ontology
  • p

  • Periodic Benefit-Risk Evaluation Report (PBRER)
  • Pharmacogenomics
  • Propensity Score
  • r

  • Real World Data (RWD)
  • Real World Evidence (RWE)
  • Reference Listed Drug (RLD)
  • Reference Safety Information [RSI]
  • Regulatory Information Management System - RIMS
  • Risk Minimization Action Plan (RiskMAP)
  • RStudio
  • s

  • Safegram
  • Safety Biomarker
  • Sequential Analysis
  • Serious Adverse Event (SAE)
  • Signal
  • Signal Detection
  • Signal Management Process
  • Signal Validation
  • Social Media Pharmacovigilance
  • Solicited Reports
  • Standardized MedDRA Queries (SMQs)
  • Summary of Product Characteristics (SMPC)
  • t

  • Targeted Medical Events (TME)
  • Temporal Relationship
  • v

  • vigiRank
  • w

  • What is a GxP?
  • What is a Product Information File (PIF)?

Primary Sidebar

Subscribe in a reader

Search Website

Uses of Generative AI in Pharmacovigilance

Featured News / Posts

Signal Analytics Technology in Pharmacovigilance

Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

Pharmacovigilance plays a crucial role in ensuring public safety by monitoring, … [Read More...] about Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

8 Common FDA Applications for Drugs & Biologics

The U.S. Food and Drug Administration (FDA) has several types of applications … [Read More...] about 8 Common FDA Applications for Drugs & Biologics

Key IND Enabling Studies: Navigating Preclinical Development Regulations

Investigational New Drug (IND) applications represent a critical stage in the … [Read More...] about Key IND Enabling Studies: Navigating Preclinical Development Regulations

Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Pharmacokinetics and pharmacodynamics are two fundamental pillars in the field … [Read More...] about Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Regulatory authorities in the pharmaceutical industry have established standards … [Read More...] about Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

In the realm of patient safety and pharmacovigilance, statistical signal … [Read More...] about Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

Pharmacovigilance signal detection software plays a crucial role in … [Read More...] about Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

A Periodic Benefit-Risk Evaluation Report (PBRER) serves as a structured … [Read More...] about What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Drug safety and pharmacovigilance are crucial aspects of public … [Read More...] about Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

he Development Safety Update Report (DSUR) is a crucial document that serves as … [Read More...] about Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

  • What is a DSUR (Development Safety Update Report)? An Essential Guide for Clinical Research
  • What is a BLA (Biologics License Application)? Essential Guide for Professionals
  • What is a PADER? – Periodic Adverse Drug Experience Report Explained

RSS ICH News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS From Nature journal

  • Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors
  • Exploratory analysis of long-term suppressive therapy with dalbavancin in ventricular assist device infections caused by Staphylococcus aureus
  • Designing and characterizing first Iranian study evaluating serum levels of lithium in patients for population pharmacokinetics (FIRELOLIPOP): baseline and first report
  • Application of new approach methodologies for nonclinical safety assessment of drug candidates
  • FAERS based disproportionality analysis and network pharmacology investigation of taxanes associated drug induced liver injury

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in